Astrana Health (ASTH) Receivables - Other (2011 - 2026)

Astrana Health has reported Receivables - Other for 16 years, with the latest figure at $28.0 million in Q1 2026.

• Quarterly Receivables - Other rose 87.79% year-over-year to $28.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.0 million (up 87.79% YoY) and the FY2025 annual result came in at $26.4 million, down 10.55% from the prior year.
• Receivables - Other improved to $28.0 million in Q1 2026 per ASTH's latest filing, from $26.4 million in the prior quarter.
• Over five years, Receivables - Other peaked at $91.2 million in Q3 2022 and troughed at -$40.2 million in Q4 2022.
• A 5-year average of $13.0 million and a median of $8.7 million in 2025 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2022 and 2024: Receivables - Other surged 1479.91% in 2022, then plunged 1488.35% in 2024.
• Over 5 years, Receivables - Other stood at -$40.2 million in 2022, then soared by 104.96% to $2.0 million in 2023, then slumped by 1488.35% to -$27.7 million in 2024, then jumped by 195.4% to $26.4 million in 2025, then grew by 6.19% to $28.0 million in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $28.0 million, $26.4 million, and $9.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.